Cargando…
First Report on Infant Acute Urticaria after Mother’s Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report
Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case...
Autores principales: | MOZAFARI, Omid, SHOROFI, Seyed Afshin, YOUSEFI, Seyde Sedighe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149476/ https://www.ncbi.nlm.nih.gov/pubmed/27957467 |
Ejemplares similares
-
Treatment of Cutaneous Leishmaniasis in Persian Medicine
por: MOZAFARI, Omid, et al.
Publicado: (2017) -
Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
por: Layegh, Pouran, et al.
Publicado: (2011) -
Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime(®)) in Cutaneous Leishmaniasis
por: Albalawi, Aishah E., et al.
Publicado: (2021) -
FIRST REPORT ON OTOTOXICITY OF MEGLUMINE
ANTIMONIATE
por: Valete-Rosalino, Cláudia Maria, et al.
Publicado: (2014) -
Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
por: Sorkhroodi, F Zamani, et al.
Publicado: (2010)